These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 28392080)
1. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial. Hanberg JS; Tang WHW; Wilson FP; Coca SG; Ahmad T; Brisco MA; Testani JM Int J Cardiol; 2017 Aug; 241():277-282. PubMed ID: 28392080 [TBL] [Abstract][Full Text] [Related]
2. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF. Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452 [TBL] [Abstract][Full Text] [Related]
3. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF. Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179 [TBL] [Abstract][Full Text] [Related]
4. Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. Testani JM; Cappola TP; Brensinger CM; Shannon RP; Kimmel SE J Am Coll Cardiol; 2011 Jul; 58(4):375-82. PubMed ID: 21757114 [TBL] [Abstract][Full Text] [Related]
5. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
6. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486 [TBL] [Abstract][Full Text] [Related]
7. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials. Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de las Fuentes L; J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026 [TBL] [Abstract][Full Text] [Related]
9. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis. Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181 [TBL] [Abstract][Full Text] [Related]
10. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit. Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139 [TBL] [Abstract][Full Text] [Related]
12. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction. Núñez J; Llàcer P; García-Blas S; Bonanad C; Ventura S; Núñez JM; Sánchez R; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Chamorro C; Bodi V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Rodríguez E; Mollar A; Palau P; Bosch MJ; Bertomeu-González V; Lupón J; Navarro J; Chorro FJ; Górriz JL; Sanchis J; Voors AA; Bayés-Genís A Am J Med; 2020 Mar; 133(3):370-380.e4. PubMed ID: 31422111 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure. Kissling KT; Pickworth KK Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816 [TBL] [Abstract][Full Text] [Related]
14. Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance. Palazzuoli A; Testani JM; Ruocco G; Pellegrini M; Ronco C; Nuti R Int J Cardiol; 2016 Dec; 224():213-219. PubMed ID: 27657476 [TBL] [Abstract][Full Text] [Related]
15. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947 [TBL] [Abstract][Full Text] [Related]
16. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial. Frea S; Pidello S; Volpe A; Canavosio FG; Galluzzo A; Bovolo V; Camarda A; Golzio PG; D'Ascenzo F; Bergerone S; Rinaldi M; Gaita F Clin Res Cardiol; 2020 Apr; 109(4):417-425. PubMed ID: 31256261 [TBL] [Abstract][Full Text] [Related]